DGS Capital Management LLC Makes New $209,000 Investment in Colgate-Palmolive (NYSE:CL)

DGS Capital Management LLC purchased a new stake in shares of Colgate-Palmolive (NYSE:CL) during the fourth quarter, Holdings Channel reports. The fund purchased 2,622 shares of the company’s stock, valued at approximately $209,000.

Several other institutional investors also recently bought and sold shares of the stock. Vest Financial LLC grew its stake in Colgate-Palmolive by 25.1% in the 4th quarter. Vest Financial LLC now owns 370,071 shares of the company’s stock valued at $29,498,000 after buying an additional 74,337 shares during the last quarter. Central Bank & Trust Co. grew its holdings in Colgate-Palmolive by 22.1% in the 4th quarter. Central Bank & Trust Co. now owns 1,383 shares of the company’s stock valued at $110,000 after buying an additional 250 shares during the last quarter. Dynamic Advisor Solutions LLC lifted its holdings in shares of Colgate-Palmolive by 9.2% during the fourth quarter. Dynamic Advisor Solutions LLC now owns 10,808 shares of the company’s stock worth $864,000 after buying an additional 910 shares during the last quarter. Sarasin & Partners LLP grew its stake in shares of Colgate-Palmolive by 1.2% in the fourth quarter. Sarasin & Partners LLP now owns 4,053,634 shares of the company’s stock worth $323,115,000 after acquiring an additional 49,980 shares during the last quarter. Finally, Cornerstone Wealth Management LLC raised its stake in Colgate-Palmolive by 2.5% during the 4th quarter. Cornerstone Wealth Management LLC now owns 7,170 shares of the company’s stock valued at $571,000 after purchasing an additional 172 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors.

Insider Activity at Colgate-Palmolive

In related news, insider Jennifer Daniels sold 3,538 shares of the firm’s stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $84.67, for a total value of $299,562.46. Following the transaction, the insider now owns 59,698 shares in the company, valued at $5,054,629.66. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In related news, insider Jennifer Daniels sold 3,538 shares of the firm’s stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $84.67, for a total value of $299,562.46. Following the transaction, the insider now owns 59,698 shares in the company, valued at $5,054,629.66. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director C Martin Harris sold 2,760 shares of the firm’s stock in a transaction dated Wednesday, January 31st. The shares were sold at an average price of $84.50, for a total value of $233,220.00. Following the completion of the transaction, the director now owns 19,272 shares in the company, valued at approximately $1,628,484. The disclosure for this sale can be found here. Insiders have sold a total of 232,371 shares of company stock worth $19,505,099 over the last 90 days. Insiders own 0.37% of the company’s stock.

Colgate-Palmolive Stock Performance

Shares of NYSE:CL opened at $86.77 on Thursday. The business’s fifty day moving average price is $86.97 and its two-hundred day moving average price is $80.63. The company has a debt-to-equity ratio of 8.59, a current ratio of 1.11 and a quick ratio of 0.71. The stock has a market capitalization of $71.32 billion, a price-to-earnings ratio of 31.21, a price-to-earnings-growth ratio of 3.28 and a beta of 0.42. Colgate-Palmolive has a fifty-two week low of $67.62 and a fifty-two week high of $90.37.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, January 26th. The company reported $0.87 EPS for the quarter, topping the consensus estimate of $0.85 by $0.02. The company had revenue of $4.95 billion for the quarter, compared to analysts’ expectations of $4.89 billion. Colgate-Palmolive had a return on equity of 509.75% and a net margin of 11.82%. The business’s revenue for the quarter was up 6.9% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.77 earnings per share. As a group, analysts predict that Colgate-Palmolive will post 3.49 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Monday, April 22nd will be issued a $0.50 dividend. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.48. The ex-dividend date of this dividend is Friday, April 19th. This represents a $2.00 annualized dividend and a yield of 2.30%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 69.06%.

Analysts Set New Price Targets

CL has been the topic of several research reports. Evercore ISI boosted their price target on Colgate-Palmolive from $90.00 to $96.00 and gave the company an “outperform” rating in a research note on Monday, April 8th. Raymond James upgraded Colgate-Palmolive from a “market perform” rating to an “outperform” rating and set a $91.00 target price for the company in a research note on Monday, January 29th. TheStreet upgraded Colgate-Palmolive from a “c+” rating to a “b+” rating in a research note on Friday, January 26th. Stifel Nicolaus upped their target price on Colgate-Palmolive from $89.00 to $94.00 and gave the company a “buy” rating in a research note on Wednesday, April 10th. Finally, Barclays upped their target price on Colgate-Palmolive from $82.00 to $84.00 and gave the company an “equal weight” rating in a research note on Friday, April 12th. Three investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $89.50.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.